-
February 12, 2021 Psychedelic Business News Spotlight: February 12, 2021This week in Psychedelic business news: MindMed has a new partner, Mydecine closes a funding...
-
February 11, 2021 BIG NEWS on MindMed’s Clinical Trials [ Important MMED/MMEDF UPDATES You Need to Know ]Hello Psychedelic Investors! Today, we will focus on MindMed's 2021 Investors Deck and Project Lucy...
-
February 6, 2021 New Psychedelic ETF (PSYK) UPDATE: What Does This Mean For MindMed, NUMI & Compass Pathways?In our previous video, we discussed the upcoming IPO of Horizons Psychedelic ETF (PSYK). Recently,...
-
February 5, 2021 Psychedelic Business News Spotlight: February 5, 2021This week in psychedelic business news, Super Mario's magic mushroom gets a new use, Mindset...
-
February 3, 2021 5-MeO-DMT: Can ‘Toad Juice’ Cure Depression?Clinical trials will look at the benefits of 5-MEO DMT as a treatment for relief...
-
February 3, 2021 The World’s First Psychedelic ETF Just Launched: Here’s Why That MattersThe Horizons Psychedelic ETF launched on the Canadian NEO stock exchange last month. Here's what...
-
February 1, 2021 How Red Light Holland Is Bringing Psilocybin Truffles MainstreamCanada's Red Light Holland is preparing to take its psilocybin truffles global as demand for...
-
January 31, 2021 MindMed’s Jr Rahn On Restructuring How We Treat Mental Health (And why he founded MindMed)Today's episode for you focuses on why C-O FOUNDER and CEO JR Rahn founded Mindmed...
-
January 29, 2021 Psychedelic Business News Spotlight: January 29, 2021This week in psychedelic business news, Psyence Group's psilocybin harvest, NeonMind's new CEO, and Mydecine...
-
January 28, 2021 How Risky is MindMed Stock? (MMED / MMEDF Risk Assessment)Today, we have a different episode for you..Usually we talk about all the things I...